Equities analysts expect Health Catalyst (NASDAQ:HCAT) to announce sales of $37.74 million for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Health Catalyst’s earnings. The lowest sales estimate is $37.40 million and the highest is $38.08 million. The company is expected to issue its next quarterly earnings report on Thursday, November 28th.
On average, analysts expect that Health Catalyst will report full-year sales of $150.67 million for the current financial year, with estimates ranging from $150.20 million to $151.47 million. For the next year, analysts expect that the company will post sales of $183.26 million, with estimates ranging from $182.00 million to $184.79 million. Zacks’ sales averages are an average based on a survey of research firms that cover Health Catalyst.
Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings results on Thursday, August 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.34) by $0.13. The firm had revenue of $36.80 million during the quarter, compared to analysts’ expectations of $36.44 million. The company’s revenue for the quarter was up 60.1% compared to the same quarter last year.
NASDAQ:HCAT traded up $1.29 during trading hours on Monday, reaching $35.33. The company’s stock had a trading volume of 162,733 shares, compared to its average volume of 342,309. Health Catalyst has a 12 month low of $32.15 and a 12 month high of $49.85.
About Health Catalyst
Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.
See Also: What is the price-sales ratio?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.